在急性中风中提供HEMERA 1 CarboxyHemoglobin oxygEn用于重血管:一个前性,随机化的第一阶段临床试验
Italo Linfante1, Wayne Clark2, Diogo C Haussen3
1Miami Neuroscience Institute Baptist Health S Florida Miami FL.
Stroke (Hoboken, N.J.)
|January 26, 2026
概括
新型气体转移分子PP-007已证明其安全性和可行性,作为接受机械血栓切除术的急性缺血性中风患者的辅助治疗. 这项研究没有发现任何重大安全问题,支持其在改善中风结果方面的潜在作用.
科学领域:
- 神经科学是一个神经科学.
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- PP-007是一种具有细胞保护性和血管扩张性质的PEGylated牛肉碳氧血球气转移分子.
- 临床前的动物模型显示,PP-007可增强附带血流并减少缺血性中风中心脏病发作的数量.
- 这项研究调查了PP-007的安全性和可行性,作为大型血管阻塞中风的机械血栓切除术 (MT) 的辅助.
研究的目的:
- 评估PP-007在急性缺血性中风患者的机械血栓切除术中使用时的安全性和可行性.
- 评估在这个患者群体中与PP-007的使用相关的耐受性和潜在不良事件.
主要方法:
- HEMERA-1试验是一项多中心,前性,随机,受控的第一阶段临床试验.
- 前部循环大血管封闭的患者在症状出现后24小时内接受PP-007加MT或单独MT.
- 安全性由独立的数据监控安全委员会和成像核心实验室监控.
主要成果:
- 招募了17名患者,12名患者接受了PP-007加MT,4名患者仅接受MT.
- 所有患者都成功地实现了封闭血管的重新通道化.
- 在接受PP-007治疗的患者中观察到暂时增加缩血压,没有临床后果;没有其他安全问题.
结论:
- 在急性缺血性中风患者中,PP-007与机械血栓切除术的辅助使用没有显著的安全问题.
- 这些发现支持PP-007作为潜在的神经保护剂在中风治疗中的可行性.
相关概念视频
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
SN1 Reaction: Stereochemistry
10.2K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.2K
SN1 Reaction: Kinetics
9.6K
In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.6K
SN1 Reaction: Mechanism
14.1K
Kinetic studies of ionization of a tertiary halide in a protic solvent suggest that only the substrate participates in the rate-determining step (slow step). The nucleophile is involved only after the slowest step. The SN1 reaction takes place in a multiple-step mechanism.
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
Firstly, the haloalkane ionizes to generate a carbocation intermediate and a halide ion. This heterolytic cleavage is highly endothermic with large activation energy. The ionization of the substrate, facilitated by a...
14.1K
Acidity of 1-Alkynes
11.1K
The acidic strength of hydrocarbons follows the order: Alkynes > Alkenes > Alkanes. The strength of an acid is commonly expressed in units of pKa — the lower the pKa, the stronger the acid. Among the hydrocarbons, terminal alkynes have lower pKa values and are, therefore, more acidic. For example, the pKa values for ethane, ethene, and acetylene are 51, 44, and 25, respectively, as shown here.
11.1K


